We established an ROP model in the Tg(fli1a:EGFP) transgenic zebrafish line by using CoCl2 as a hypoxia-inducing agent and a VEGF-inducer, GS4012, as a vasoproliferative agent to induce the two phases of ROP. The gene discussed is VEGFA; the disease is retinopathy of prematurity.